These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11898804)

  • 1. Discrepancies between medical and pharmacy records for patients on anti-HIV drugs.
    de Maat MM; Frankfort SV; Mathôt RA; Mulder JW; Meenhorst PL; van Gorp EC; Koks CH; Hoetelmans RM; de Boer A; Beijnen JH
    Ann Pharmacother; 2002 Mar; 36(3):410-5. PubMed ID: 11898804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent use of comedications reduces adherence to antiretroviral therapy among HIV-infected patients.
    Cantudo-Cuenca MR; Jiménez-Galán R; Almeida-Gonzalez CV; Morillo-Verdugo R
    J Manag Care Spec Pharm; 2014 Aug; 20(8):844-50. PubMed ID: 25062078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrepancies between medication records of anticoagulation clinics and pharmacy records.
    Schalekamp T; Smit C; van Geest-Daalderop JH; de Vries-Goldschmeding H; de Boer A
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):823-8. PubMed ID: 16835939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a strategy aimed at reducing errors in antiretroviral prescriptions for hospitalized HIV-infected patients.
    Lauzevis S; Chaix F; Lazzerini C
    Med Mal Infect; 2013 Sep; 43(9):391-7. PubMed ID: 23973400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of adherence rates for antiretroviral, blood pressure, or mental health medications for HIV-positive patients at an academic medical center outpatient pharmacy.
    Langness J; Cook PF; Gill J; Boggs R; Netsanet N
    J Manag Care Spec Pharm; 2014 Aug; 20(8):809-14. PubMed ID: 25062074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictive factors of clinically significant drug-drug interactions among regimens based on protease inhibitors, non-nucleoside reverse transcriptase inhibitors and raltegravir].
    Cervero M; Torres R; Jusdado JJ; Pastor S; Agud JL
    Med Clin (Barc); 2016 Apr; 146(8):339-45. PubMed ID: 26971988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-related problems in hospitalized patients with HIV infection.
    Mok S; Minson Q
    Am J Health Syst Pharm; 2008 Jan; 65(1):55-9. PubMed ID: 18159040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between pharmacy medication refill-based adherence rates and cd4 count and viral-load responses: A retrospective analysis in treatment-experienced adults with HIV.
    Townsend ML; Jackson GL; Smith R; Wilson KH
    Clin Ther; 2007 Apr; 29(4):711-6. PubMed ID: 17617294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.
    Hirsch JD; Rosenquist A; Best BM; Miller TA; Gilmer TP
    J Manag Care Pharm; 2009; 15(1):32-41. PubMed ID: 19125548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting.
    Fairley CK; Permana A; Read TR
    HIV Med; 2005 Sep; 6(5):366-9. PubMed ID: 16156886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perception of antiretroviral generic medicines: one-day survey of HIV-infected patients and their physicians in France.
    Jacomet C; Allavena C; Peyrol F; Pereira B; Joubert LM; Bagheri H; Cotte L; Garaffo R; Gerbaud L; Dellamonica P
    PLoS One; 2015; 10(2):e0117214. PubMed ID: 25658627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of self-reported adherence among injection drug users.
    Kerr T; Hogg RS; Yip B; Tyndall MW; Montaner J; Wood E
    J Int Assoc Physicians AIDS Care (Chic); 2008; 7(4):157-9. PubMed ID: 18626123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal trends in antiretroviral use in a cohort of men and women in Ontario, Canada.
    Furler MD; Einarson TR; Walmsley S; Millson M; Bendayan R
    AIDS Patient Care STDS; 2006 Apr; 20(4):245-57. PubMed ID: 16623623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a role for generic antiretroviral drugs in the United States?
    Wormser GP; Lappas T
    Expert Rev Anti Infect Ther; 2014 Aug; 12(8):897-9. PubMed ID: 24918192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV/AIDS patient's satisfactory and their expectations with pharmacy service at specialist antiretroviral therapy (ART) units.
    Karunamoorthi K; Rajalakshmi M; Babu SM; Yohannes A
    Eur Rev Med Pharmacol Sci; 2009; 13(5):331-9. PubMed ID: 19961038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring adherence to antiretroviral treatment: the role of pharmacy records of drug withdrawals.
    Gutierrez EB; Sartori AM; Schmidt AL; Piloto BM; França BB; de Oliveira AS; Pouza AR; Moreno RV; de Melo Picone C; de Almeida Ribeiro MC
    AIDS Behav; 2012 Aug; 16(6):1482-90. PubMed ID: 22392157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generic antiretroviral drugs are a credible and cheaper alternative to brands.
    BMJ; 2013 Jan; 346():f250. PubMed ID: 23325870
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of clinical pharmacist interventions on drug interactions in outpatient pharmaceutical HIV-care.
    de Maat MM; de Boer A; Koks CH; Mulder JW; Meenhorst PL; van Gorp EC; Mairuhu AT; Huitema AD; Beijnen JH
    J Clin Pharm Ther; 2004 Apr; 29(2):121-30. PubMed ID: 15068400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adherence to antiretroviral treatment evaluated from a hospital pharmacy: importance of the protease inhibitors pharmacological class.
    Rubio M; Pédeboscq S; Ekouevi D; Zalabadi K; Chêne G; Bonarek M; Pometan JP
    Int J STD AIDS; 2005 May; 16(5):379-82. PubMed ID: 15949070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.